These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6866153)

  • 1. [The admission of drugs in the Netherlands].
    ten Ham M
    Ned Tijdschr Geneeskd; 1983 May; 127(22):968-71. PubMed ID: 6866153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences in approving drugs].
    Schnieders B
    Internist (Berl); 1980 Jun; 21(6):325-32. PubMed ID: 7005169
    [No Abstract]   [Full Text] [Related]  

  • 3. [Towards a new drug management].
    Hoffmann M; Ahlner J
    Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634
    [No Abstract]   [Full Text] [Related]  

  • 4. [More stringent requirements in connection with the choice of drugs. Members of the drug committees in Stockholm deliver an annual declaration of challengeability].
    Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):541-3. PubMed ID: 11475240
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs and the Washington climate.
    Durant TM
    Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Responsibility for drug reactions].
    Naess K
    Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug trials. Reform or modification of the current system].
    Lemaire A
    Nouv Presse Med; 1975 May; 4(18):1367-71. PubMed ID: 1098017
    [No Abstract]   [Full Text] [Related]  

  • 8. The other side of the fence: hospital P&T committee members' role in drug selection.
    Archambault GF
    Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-use evaluation of thrombolytic agents: a challenge to pharmacists.
    Green JA
    Am J Hosp Pharm; 1988 Oct; 45(10):2192-4. PubMed ID: 3228086
    [No Abstract]   [Full Text] [Related]  

  • 10. Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
    Ishizaki T; Sugita M
    Clin Pharmacol Ther; 1974 Sep; 16(3):577-84. PubMed ID: 4415183
    [No Abstract]   [Full Text] [Related]  

  • 11. $50 M for drug comparisons could produce valuable results.
    Carroll J
    Manag Care; 2004 Apr; 13(4):9-10. PubMed ID: 15146713
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioactive drugs in Sweden].
    Aberg B
    Nord Med; 1971 Nov; 86(47):1387-8. PubMed ID: 5138078
    [No Abstract]   [Full Text] [Related]  

  • 13. When the pharmacy and therapeutics committee decides.
    Garrison TJ
    Hosp Pharm; 1979 Sep; 14(9):506-7. PubMed ID: 10243912
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacotherapy between theory and practice].
    Stricker BH
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2295-6. PubMed ID: 7501059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug committee: committee is going to bring about a more knowledgeable attitude to the selection of drugs].
    Hagelsten JO
    Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 247708
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a need for critical ethical and philosophical evaluation of hospital drugs and therapeutics (D&T) committees?
    Fijn R; van Epenhuysen LS; Peijnenburg AJ; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):247-52. PubMed ID: 12058711
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential conflict of interest of a pharmacy and therapeutics committee member.
    Am J Hosp Pharm; 1989 Oct; 46(10):2047-9; discussion 2049-51. PubMed ID: 2816960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Editorial: Information committee of the drug industry].
    Naes K
    Tidsskr Nor Laegeforen; 1975 Oct; 95(30):1748-9. PubMed ID: 1188879
    [No Abstract]   [Full Text] [Related]  

  • 19. [Letter: The role of the National Board of Health and Welfare in drug information].
    Liljestrand A; Rosén A
    Lakartidningen; 1976; 73(20):1881-2. PubMed ID: 1271917
    [No Abstract]   [Full Text] [Related]  

  • 20. [Round table discussion on the Scandinavian drug market: A common pharmacy and therapeutics committee is proposed in view of threats from abroad of lowered standards].
    Nord Med; 1974 Jan; 89(1):3-5. PubMed ID: 4856475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.